We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Rejects Merck’s ANDA-Blocker Petition on Nasonex-Reliant Products
FDA Rejects Merck’s ANDA-Blocker Petition on Nasonex-Reliant Products
January 2, 2013
The FDA has rejected a second bid by Merck to block Apotex’s ANDA prospects on Nasonex.